Development of sarcoidosis during Interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C - A case report and review of the literature

Acta Gastro-Enterologica Belgica

Volumn 68, Issue 4, 2005, Pages 432-434

  Bolukbas, Cengiz ^a,c   Bolukbas, F F ^a   Kebdir, T ^b   Canayaz, L ^b   Dalay Y, A R ^b   Kilic, Gy ^b   Ovunc, O ^b  

^a HARRAN UNIVERSITY   (Turkey)

^b GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^c Yenisehir Mah   (Turkey)

Author keywords

Hepatitis C; Interferon; Ribavirin; Sarcoidosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BUDESONIDE; HEPATITIS C ANTIBODY; PEGINTERFERON; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; STEROID; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CHRONIC HEPATITIS; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DYSPNEA; FEMALE; FEVER; HEPATITIS C; HUMAN; IMMUNOTHERAPY; LIVER FUNCTION TEST; LUNG FUNCTION TEST; LUNG SARCOIDOSIS; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MEDIASTINUM LYMPH NODE; REMISSION; SARCOIDOSIS; STEROID THERAPY; THORAX RADIOGRAPHY; TREATMENT OUTCOME; VIRUS HEPATITIS;

ABDOMINAL PAIN; BIOPSY, NEEDLE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON ALFA-2B; LIVER FUNCTION TESTS; MIDDLE AGED; RIBAVIRIN; RISK ASSESSMENT; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED;

EID: 30344438526     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. MOLLER D.R. Etiology of sarcoidosis. Clin Chest Med. 1997, 18: 695-706.
2. PINKSTON P., BITTERMAN P.B., CRYSTAL R.G. Spontaneous release of interleukin-2 by lung T-lymphocytes in active pulmonary sarcoidosis. N Engl J Med. 1983, 308: 793-800.
3. ROBINSON B.W., MCLEMORE T.L., CRYSTAL R.G. Gamma interferon is spontaneously released by alveolar macrophages and lung T-lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest, 1985, 75: 1488-1495.
4. PEREZ-ALVAREZ R., PEREZ-LOPEZ R., LOMBRANA J.L., RODRIGUEZ M., RODRIGO L. Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine. J Viral Hepat. 2002, 9: 75-79.
5. PIETROPAOLI A., MODRAK J., UTELL M. Interferon-alpha therapy associated with the development of sarcoidosis. Chest. 1999, 116: 569-572.
6. VANDER ELS N.J., Gerdes H. Sarcoidosis and IFN-alpha treatment. Chest. 2000, 117: 294.
7. TAHAN V., OZSEKER E., GUNEYLIOGLU D., BARAN A., OZARAS R., MERT A., UCISIK A.C., CAGATAY T., YILMAZBAYHAN D., SENTURK H. Sarcoidosis after use of interferon for chronic hepatitis C. Dig Dis Sci. 2003, 48: 169-173.
8. OKANOUE T., SAKAMOTO S., ITOH Y., MINAMI M., YASUI K., SAKAMOTO M., NISHIOJI K., KATAGISHI T., NAKAGAWA Y., TADA H., SAWA Y. MIZUNO M., KAGAWA K., KASHIMA K. Side effects of high-dose Interferon therapy for chronic hepatitis C. J Hepatol. 1996, 25: 283-291.
9. SEN G.C. The interferons. In Cytokines in health and disease. Edited by REMICK D.G., FRIEDLAND J.S., New York: Marcel Dekkert. 1997: 199-208.
10. NUGENT K.M., GLAZIER J., MONICK M.M., HUNNINGHAKe G.W. Stimulated human alveolar macrophages secrete interferon. Ann Rev Respir Dis. 1985, 131: 714-718.
11. FELS A.O., NATHAN C.F., COHN Z.A. Hydrogen peroxide release by alveolar macrophages from sarcoid patients and by alveolar macrophages from normals after exposure to recombinant Interferon alpha, beta, and gamma and 1. 25-dihydroxyvitamin D3. J Clin Invest. 1987, 80: 381-386.
12. KUBO K., YAMAGUCHI S., FUJIMOTO K., HANAOKA M., HAYASAKA M., HONDA T., SODEYAMA T., KIYOSAWA K. Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection. Thorax. 1996, 51: 312-314.
13. YAMAGUCHI S., KUBO K., FUJIMOTO K., HONDA T., SEKlGUCHI M., SODEYAMA T. Analysis of bronchoalveolar lavage fluid in patients with chronic hepatitis C before and after treatment with interferon alpha. Thorax. 1997, 52: 33-37.
14. UEDA T., OHTA K., SUZUKI N., YAMAGUCHI M., HIRAI K., HORIUCHI T., WATANABE J., MIYAMOTO T., ITO K. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Rexpir Dis. 1992, 146: 266-268.
15. MELICONI R., ANDREONE P., FASANO L., GALLI S., PACILLI A., MlNlERO R., FABBRI M., SOEFOROSI L., BERNARDI M. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. Thorax. 1996, 51: 315-317.
16. SHIOMI S., KUROKI T., YOKOGAWA T., TAKEDA T., NISHIGUCHI S., NAKAJIMA S., TANAKA T., OKAMURA T., OCHI H. Changes in results of gallium -citrate scanning after interteron therapy for chronic hepatitis C. J Nucl Med. 1997, 38: 216-219.
17. NING Q., BROWN D., PARODO J., CATTRAL M., GORCZYNSKI R., COLE E., FUNG L., DING J.W., LIU M.F., ROTSTEIN O., PHILLIPS M.J., LEVY G. Ribavirin inhibits viral-induced macrophage production of TNF. IL-1. the procoagulant fg12 prothromhinase and preserves Th1 cytokine production hut inhibits Th2 cytokine response. J Immunol. 1998, 160: 3487-3493.
18. HOFFMANN R.M., JUNG M.C., MOTZ R., GOSSI C., EMSEANDER H.P., ZACHOVAE R., PAPE G.R. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. J Hepatol. 1998, 28: 1058-1063.
19. ALFAGEME MICHAVILA I., MERINO SANCHEZ M., PEREZ RONCHEL J., LARA LARA I., SUAREZ GARCIA E., LOPEZ GARRIDO J. Sarcoidosis following combined ribavirin and interteron therapy: a case report and review of the literature. Arch Bronconeumol. 2004, 40: 45-49.
20. FABRI M., BOZIC M., DELIC D., JESIC R., NOZIC D. Treatment of chronic hepatitis C with PEG-interferon. Med Pregl. 2003, 56: 427-430.
21. GITLIN N. Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases. Eur J Gastroenterol Hepatol. 2002, 14: 883-885.
22. WENDLING J., DESCAMPS V., GROSSIN M., MARCELLIN P., LE BOZEC P., BELAICH S., CRICKX B. Sarcoidosis during combined interferon alia and ribavirin therapy in 2 patients with chronic hepatitis C. Arch Dermatol. 2002, 138: 546-547.
23. COGREL O., DOUTRE M.S., MARLIERE V., BEYLOT-BARRY M., COUZIGOU P., BEYLOT C. Cutaneous sarcoidosis during interteron alfa and ribavirin treatment of hepatitis C virus infection: two cases. Br J Dermatol. 2002, 146: 320-324.
24. LEVEQUE L., DE BOULARD A., BIELEFELD P., SGRO C., HILLON P., GABREAU T. CHAMPIGNEULLE B., MAKKI H., BESANCENOT J.F. Sarcoidosis during the treatment of hepatitis C by interferon-alpha and ribavirin: 2 cases. Rev Med Interne. 2001, 22: 1248-1252.
25. POHL J., STREMMEL W., KALLINOWSKI B. Pulmonal sarcoidosis: A rare side effect of interferon-alpha treatment for chronic hepatitis C infection. Z Gastroenterol. 2000, 38: 951-955.
26. SAVOYE G., GORIA O., HERVE S., RIACHI G., NOBLESSE I., BASTIEN L., COURVILLE P., LEREBOURS E. Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C. Gastroenterol Clin Biol. 2000, 24: 679.